Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities

doi:10.3748/wjg.v23.i47.8283

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 47

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9423)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

654

WORD

202

HTML

5418

Figures (1-3)

192

Tables (1-1)

150

Sum=6616

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

665

Download

475

Sum=1140

Publishing Process of This Article

Item

Count

Browse

972

Download

695

Sum=1667

Dec 21, 2017 (publication date) through May 18, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Dec 21, 2017; 23(47): 8283-8290
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8283

Full Size Figure Download Figure

Figure 1 Biochemistry and biology of procalcitonin. N-PCT: N-terminal procalcitonin; PC: Prohormone convertase; pre-PCT: Pre-procalcitonin; PCT: Procalcitonin.

Citation: Lippi G, Sanchis-Gomar F. Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities. World J Gastroenterol 2017; 23(47): 8283-8290
URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8283.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8283